View in EDS

Nomogram-based risk classification for predicting response to metastasis-directed stereotactic body radiotherapy in PSMA PET-staged oligorecurrent prostate cancer (PORTAL): an international, retrospective cohort study.

Saved in:
Bibliographic Details
Title: Nomogram-based risk classification for predicting response to metastasis-directed stereotactic body radiotherapy in PSMA PET-staged oligorecurrent prostate cancer (PORTAL): an international, retrospective cohort study.
Authors: Soeterik TFW; Department of Radiation Oncology, University Medical Center Utrecht, Utrecht, Netherlands. Electronic address: t.f.w.soeterik@umcutrecht.nl., Miszczyk M; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria; Collegium Medicum - Faculty of Medicine, WSB University, Dąbrowa Górnicza, Poland., Peters M; Department of Radiation Oncology, University Medical Center Utrecht, Utrecht, Netherlands; Department of Radiation Oncology, Radiotherapiegroep, Deventer/Arnhem, Netherlands., Bilski M; Radiotherapy Department, Affidea Nu-med Centre of Oncology Diagnostics and Therapy, Zamość, Poland; Clinics of Radiotherapy, Medical University of Lublin, Lublin, Poland., Francolini G; Department of Radiation Oncology, Azienda Ospedaliero-Universitaria Careggi, University of Florence, Florence, Italy., Garlatti P; Department of Radiation Oncology, Azienda Ospedaliero-Universitaria Careggi, University of Florence, Florence, Italy., Nicosia L; Department of Advanced Radiation Oncology, IRCCS Sacro Cuore Don Calabria Hospital, Cancer Care Centre, Negrar di Valpolicella, Italy., Alongi F; Department of Advanced Radiation Oncology, IRCCS Sacro Cuore Don Calabria Hospital, Cancer Care Centre, Negrar di Valpolicella, Italy; University of Brescia, Brescia, Italy., Mezeckis M; University of Latvia, Riga, Latvia; Sigulda Hospital Centre of Stereotactic Radiosurgery, Sigulda, Latvia., Kociolek J; Department of Radiation Oncology, Champalimaud Centre for the Unknown, Lisbon, Portugal., Greco C; Department of Radiation Oncology, Champalimaud Centre for the Unknown, Lisbon, Portugal., Techmański T; 3rd Department of Radiotherapy and Chemotherapy, Maria Skłodowska-Curie National Research Institute of Oncology, Gliwice, Poland., Huele EH; Division of Imaging and Oncology, University Medical Centre Utrecht, Utrecht, Netherlands., Teunissen FR; Department of Radiation Oncology, Radboud University Medical Centre, Nijmegen, Netherlands., Westhoff PG; Department of Radiation Oncology, Radboud University Medical Centre, Nijmegen, Netherlands., Vis W; Department of Radiation Oncology, Radiotherapiegroep, Deventer/Arnhem, Netherlands., Haverkort MAD; Department of Radiation Oncology, Radiotherapiegroep, Deventer/Arnhem, Netherlands., van der Voort van Zyp JRN; Department of Radiation Oncology, University Medical Center Utrecht, Utrecht, Netherlands., Intven MPW; Department of Radiation Oncology, University Medical Center Utrecht, Utrecht, Netherlands., van der Velden JM; Department of Radiation Oncology, University Medical Center Utrecht, Utrecht, Netherlands., Shariat SF; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria; Institute for Urology and Reproductive Health, Sechenov University, Moscow, Russia; Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX, USA; Department of Urology, Weill Cornell Medical College, New York, NY, USA; Department of Urology, Second Faculty of Medicine, Charles University, Prague, Czechia; Division of Urology, Department of Special Surgery, The University of Jordan, Amman, Jordan; Karl Landsteiner Institute of Urology and Andrology, Vienna, Austria; Department of Urology, Semmelweis University, Budapest, Hungary; Research Centre for Evidence Medicine, Urology Department, Tabriz University of Medical Sciences, Tabriz, Iran., Eppinga WSC; Department of Radiation Oncology, University Medical Center Utrecht, Utrecht, Netherlands.
Source: The Lancet. Oncology [Lancet Oncol] 2026 Mar; Vol. 27 (3), pp. 383-392. Date of Electronic Publication: 2026 Feb 16.
Publication Type: Journal Article; Multicenter Study
Journal Info: Publisher: Lancet Pub. Group Country of Publication: England NLM ID: 100957246 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1474-5488 (Electronic) Linking ISSN: 14702045 NLM ISO Abbreviation: Lancet Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41713474
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Nomogram-based risk classification for predicting response to metastasis-directed stereotactic body radiotherapy in PSMA PET-staged oligorecurrent prostate cancer (PORTAL): an international, retrospective cohort study.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Soeterik+TFW%22">Soeterik TFW</searchLink>; Department of Radiation Oncology, University Medical Center Utrecht, Utrecht, Netherlands. Electronic address: t.f.w.soeterik@umcutrecht.nl.<br /><searchLink fieldCode="AU" term="%22Miszczyk+M%22">Miszczyk M</searchLink>; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria; Collegium Medicum - Faculty of Medicine, WSB University, Dąbrowa Górnicza, Poland.<br /><searchLink fieldCode="AU" term="%22Peters+M%22">Peters M</searchLink>; Department of Radiation Oncology, University Medical Center Utrecht, Utrecht, Netherlands; Department of Radiation Oncology, Radiotherapiegroep, Deventer/Arnhem, Netherlands.<br /><searchLink fieldCode="AU" term="%22Bilski+M%22">Bilski M</searchLink>; Radiotherapy Department, Affidea Nu-med Centre of Oncology Diagnostics and Therapy, Zamość, Poland; Clinics of Radiotherapy, Medical University of Lublin, Lublin, Poland.<br /><searchLink fieldCode="AU" term="%22Francolini+G%22">Francolini G</searchLink>; Department of Radiation Oncology, Azienda Ospedaliero-Universitaria Careggi, University of Florence, Florence, Italy.<br /><searchLink fieldCode="AU" term="%22Garlatti+P%22">Garlatti P</searchLink>; Department of Radiation Oncology, Azienda Ospedaliero-Universitaria Careggi, University of Florence, Florence, Italy.<br /><searchLink fieldCode="AU" term="%22Nicosia+L%22">Nicosia L</searchLink>; Department of Advanced Radiation Oncology, IRCCS Sacro Cuore Don Calabria Hospital, Cancer Care Centre, Negrar di Valpolicella, Italy.<br /><searchLink fieldCode="AU" term="%22Alongi+F%22">Alongi F</searchLink>; Department of Advanced Radiation Oncology, IRCCS Sacro Cuore Don Calabria Hospital, Cancer Care Centre, Negrar di Valpolicella, Italy; University of Brescia, Brescia, Italy.<br /><searchLink fieldCode="AU" term="%22Mezeckis+M%22">Mezeckis M</searchLink>; University of Latvia, Riga, Latvia; Sigulda Hospital Centre of Stereotactic Radiosurgery, Sigulda, Latvia.<br /><searchLink fieldCode="AU" term="%22Kociolek+J%22">Kociolek J</searchLink>; Department of Radiation Oncology, Champalimaud Centre for the Unknown, Lisbon, Portugal.<br /><searchLink fieldCode="AU" term="%22Greco+C%22">Greco C</searchLink>; Department of Radiation Oncology, Champalimaud Centre for the Unknown, Lisbon, Portugal.<br /><searchLink fieldCode="AU" term="%22Techmański+T%22">Techmański T</searchLink>; 3rd Department of Radiotherapy and Chemotherapy, Maria Skłodowska-Curie National Research Institute of Oncology, Gliwice, Poland.<br /><searchLink fieldCode="AU" term="%22Huele+EH%22">Huele EH</searchLink>; Division of Imaging and Oncology, University Medical Centre Utrecht, Utrecht, Netherlands.<br /><searchLink fieldCode="AU" term="%22Teunissen+FR%22">Teunissen FR</searchLink>; Department of Radiation Oncology, Radboud University Medical Centre, Nijmegen, Netherlands.<br /><searchLink fieldCode="AU" term="%22Westhoff+PG%22">Westhoff PG</searchLink>; Department of Radiation Oncology, Radboud University Medical Centre, Nijmegen, Netherlands.<br /><searchLink fieldCode="AU" term="%22Vis+W%22">Vis W</searchLink>; Department of Radiation Oncology, Radiotherapiegroep, Deventer/Arnhem, Netherlands.<br /><searchLink fieldCode="AU" term="%22Haverkort+MAD%22">Haverkort MAD</searchLink>; Department of Radiation Oncology, Radiotherapiegroep, Deventer/Arnhem, Netherlands.<br /><searchLink fieldCode="AU" term="%22van+der+Voort+van+Zyp+JRN%22">van der Voort van Zyp JRN</searchLink>; Department of Radiation Oncology, University Medical Center Utrecht, Utrecht, Netherlands.<br /><searchLink fieldCode="AU" term="%22Intven+MPW%22">Intven MPW</searchLink>; Department of Radiation Oncology, University Medical Center Utrecht, Utrecht, Netherlands.<br /><searchLink fieldCode="AU" term="%22van+der+Velden+JM%22">van der Velden JM</searchLink>; Department of Radiation Oncology, University Medical Center Utrecht, Utrecht, Netherlands.<br /><searchLink fieldCode="AU" term="%22Shariat+SF%22">Shariat SF</searchLink>; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria; Institute for Urology and Reproductive Health, Sechenov University, Moscow, Russia; Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX, USA; Department of Urology, Weill Cornell Medical College, New York, NY, USA; Department of Urology, Second Faculty of Medicine, Charles University, Prague, Czechia; Division of Urology, Department of Special Surgery, The University of Jordan, Amman, Jordan; Karl Landsteiner Institute of Urology and Andrology, Vienna, Austria; Department of Urology, Semmelweis University, Budapest, Hungary; Research Centre for Evidence Medicine, Urology Department, Tabriz University of Medical Sciences, Tabriz, Iran.<br /><searchLink fieldCode="AU" term="%22Eppinga+WSC%22">Eppinga WSC</searchLink>; Department of Radiation Oncology, University Medical Center Utrecht, Utrecht, Netherlands.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22100957246%22">The Lancet. Oncology</searchLink> [Lancet Oncol] 2026 Mar; Vol. 27 (3), pp. 383-392. <i>Date of Electronic Publication: </i>2026 Feb 16.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Multicenter Study
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Lancet+Pub%2E+Group%22">Lancet Pub. Group </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>100957246 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1474-5488 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2214702045%22">14702045 </searchLink><i>NLM ISO Abbreviation: </i>Lancet Oncol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41713474
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/S1470-2045(25)00717-X
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 383
    Titles:
      – TitleFull: Nomogram-based risk classification for predicting response to metastasis-directed stereotactic body radiotherapy in PSMA PET-staged oligorecurrent prostate cancer (PORTAL): an international, retrospective cohort study.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Soeterik TFW
      – PersonEntity:
          Name:
            NameFull: Miszczyk M
      – PersonEntity:
          Name:
            NameFull: Peters M
      – PersonEntity:
          Name:
            NameFull: Bilski M
      – PersonEntity:
          Name:
            NameFull: Francolini G
      – PersonEntity:
          Name:
            NameFull: Garlatti P
      – PersonEntity:
          Name:
            NameFull: Nicosia L
      – PersonEntity:
          Name:
            NameFull: Alongi F
      – PersonEntity:
          Name:
            NameFull: Mezeckis M
      – PersonEntity:
          Name:
            NameFull: Kociolek J
      – PersonEntity:
          Name:
            NameFull: Greco C
      – PersonEntity:
          Name:
            NameFull: Techmański T
      – PersonEntity:
          Name:
            NameFull: Huele EH
      – PersonEntity:
          Name:
            NameFull: Teunissen FR
      – PersonEntity:
          Name:
            NameFull: Westhoff PG
      – PersonEntity:
          Name:
            NameFull: Vis W
      – PersonEntity:
          Name:
            NameFull: Haverkort MAD
      – PersonEntity:
          Name:
            NameFull: van der Voort van Zyp JRN
      – PersonEntity:
          Name:
            NameFull: Intven MPW
      – PersonEntity:
          Name:
            NameFull: van der Velden JM
      – PersonEntity:
          Name:
            NameFull: Shariat SF
      – PersonEntity:
          Name:
            NameFull: Eppinga WSC
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 03
              Text: 2026 Mar
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1474-5488
          Numbering:
            – Type: volume
              Value: 27
            – Type: issue
              Value: 3
          Titles:
            – TitleFull: The Lancet. Oncology
              Type: main
ResultId 1